vs
Bark, Inc.（BARK）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Bark, Inc.的1.3倍（$127.1M vs $98.4M），再鼎医药同比增速更快（17.1% vs -22.1%），Bark, Inc.自由现金流更多（$1.6M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -10.0%）
飞狗制片公司（Flying Bark Productions）是一家澳大利亚娱乐动画工作室，现为比利时制片公司Studio 100的旗下子公司。该工作室是提供全流程服务的制片机构，业务覆盖院线电影、电视内容及各类数字内容制作。工作室最初由约拉姆·格罗斯与桑德拉·格罗斯于1967年创立，原名约拉姆·格罗斯电影工作室，1996年被澳大利亚威秀集团收购股份，后股份转售给德国传媒集团。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
BARK vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.3倍
$98.4M
营收增速更快
ZLAB
高出39.3%
-22.1%
自由现金流更多
BARK
多$28.3M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-10.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $98.4M | $127.1M |
| 净利润 | $-8.6M | — |
| 毛利率 | 62.5% | 51.0% |
| 营业利润率 | -9.1% | -54.6% |
| 净利率 | -8.8% | — |
| 营收同比 | -22.1% | 17.1% |
| 净利润同比 | 24.9% | — |
| 每股收益（稀释后） | $-0.05 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BARKZLAB
| Q4 25 | $98.4M | $127.1M | ||
| Q3 25 | $107.0M | $115.4M | ||
| Q2 25 | $102.9M | $109.1M | ||
| Q1 25 | $115.4M | $105.7M | ||
| Q4 24 | $126.4M | $108.5M | ||
| Q3 24 | $126.1M | $101.8M | ||
| Q2 24 | $116.2M | $100.1M | ||
| Q1 24 | $121.5M | $87.1M |
净利润BARKZLAB
| Q4 25 | $-8.6M | — | ||
| Q3 25 | $-10.7M | $-36.0M | ||
| Q2 25 | $-7.0M | $-40.7M | ||
| Q1 25 | $-6.1M | $-48.4M | ||
| Q4 24 | $-11.5M | — | ||
| Q3 24 | $-5.3M | $-41.7M | ||
| Q2 24 | $-10.0M | $-80.3M | ||
| Q1 24 | $-4.9M | $-53.5M |
毛利率BARKZLAB
| Q4 25 | 62.5% | 51.0% | ||
| Q3 25 | 57.9% | 59.5% | ||
| Q2 25 | 62.3% | 60.6% | ||
| Q1 25 | 63.6% | 63.6% | ||
| Q4 24 | 62.7% | 61.5% | ||
| Q3 24 | 60.4% | 64.1% | ||
| Q2 24 | 63.0% | 64.9% | ||
| Q1 24 | 62.8% | 61.4% |
营业利润率BARKZLAB
| Q4 25 | -9.1% | -54.6% | ||
| Q3 25 | -10.0% | -42.3% | ||
| Q2 25 | -8.1% | -50.3% | ||
| Q1 25 | -5.7% | -53.3% | ||
| Q4 24 | -9.7% | -62.6% | ||
| Q3 24 | -4.5% | -66.6% | ||
| Q2 24 | -9.1% | -76.0% | ||
| Q1 24 | -5.3% | -80.7% |
净利率BARKZLAB
| Q4 25 | -8.8% | — | ||
| Q3 25 | -10.0% | -31.2% | ||
| Q2 25 | -6.8% | -37.3% | ||
| Q1 25 | -5.3% | -45.8% | ||
| Q4 24 | -9.1% | — | ||
| Q3 24 | -4.2% | -40.9% | ||
| Q2 24 | -8.6% | -80.2% | ||
| Q1 24 | -4.0% | -61.4% |
每股收益（稀释后）BARKZLAB
| Q4 25 | $-0.05 | $-0.05 | ||
| Q3 25 | $-0.06 | $-0.03 | ||
| Q2 25 | $-0.04 | $-0.04 | ||
| Q1 25 | $-0.03 | $-0.04 | ||
| Q4 24 | $-0.07 | $-0.09 | ||
| Q3 24 | $-0.03 | $-0.04 | ||
| Q2 24 | $-0.06 | $-0.08 | ||
| Q1 24 | $-0.02 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.7M | $689.6M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $81.2M | $715.5M |
| 总资产 | $188.7M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资BARKZLAB
| Q4 25 | $21.7M | $689.6M | ||
| Q3 25 | $63.4M | $717.2M | ||
| Q2 25 | $84.7M | $732.2M | ||
| Q1 25 | $94.0M | $757.3M | ||
| Q4 24 | $115.3M | $779.7M | ||
| Q3 24 | $115.2M | $616.1M | ||
| Q2 24 | $117.8M | $630.0M | ||
| Q1 24 | $125.5M | $650.8M |
总债务BARKZLAB
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $42.6M | — | ||
| Q4 24 | $42.5M | — | ||
| Q3 24 | $40.1M | — | ||
| Q2 24 | $40.0M | — | ||
| Q1 24 | $39.9M | — |
股东权益BARKZLAB
| Q4 25 | $81.2M | $715.5M | ||
| Q3 25 | $86.5M | $759.9M | ||
| Q2 25 | $94.0M | $791.7M | ||
| Q1 25 | $99.5M | $810.8M | ||
| Q4 24 | $113.0M | $840.9M | ||
| Q3 24 | $123.6M | $667.7M | ||
| Q2 24 | $128.1M | $704.2M | ||
| Q1 24 | $139.4M | $762.2M |
总资产BARKZLAB
| Q4 25 | $188.7M | $1.2B | ||
| Q3 25 | $248.0M | $1.2B | ||
| Q2 25 | $260.0M | $1.2B | ||
| Q1 25 | $260.6M | $1.2B | ||
| Q4 24 | $292.2M | $1.2B | ||
| Q3 24 | $301.6M | $985.3M | ||
| Q2 24 | $287.7M | $987.4M | ||
| Q1 24 | $298.6M | $988.4M |
负债/权益比BARKZLAB
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.43× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.31× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-26.7M |
| 自由现金流率自由现金流/营收 | 1.6% | -21.0% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-36.5M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流BARKZLAB
| Q4 25 | $1.7M | $-26.0M | ||
| Q3 25 | $-18.1M | $-32.0M | ||
| Q2 25 | $-5.4M | $-31.0M | ||
| Q1 25 | $-10.3M | $-61.7M | ||
| Q4 24 | $-1.4M | $-55.8M | ||
| Q3 24 | $2.8M | $-26.8M | ||
| Q2 24 | $1.8M | $-42.2M | ||
| Q1 24 | $-1.0M | $-90.1M |
自由现金流BARKZLAB
| Q4 25 | $1.6M | $-26.7M | ||
| Q3 25 | $-19.9M | $-35.0M | ||
| Q2 25 | $-6.1M | $-33.9M | ||
| Q1 25 | $-12.0M | $-63.2M | ||
| Q4 24 | $-2.0M | $-58.4M | ||
| Q3 24 | $966.0K | $-28.2M | ||
| Q2 24 | $-251.0K | $-42.9M | ||
| Q1 24 | $-3.2M | $-91.1M |
自由现金流率BARKZLAB
| Q4 25 | 1.6% | -21.0% | ||
| Q3 25 | -18.6% | -30.4% | ||
| Q2 25 | -6.0% | -31.1% | ||
| Q1 25 | -10.4% | -59.9% | ||
| Q4 24 | -1.6% | -53.8% | ||
| Q3 24 | 0.8% | -27.7% | ||
| Q2 24 | -0.2% | -42.9% | ||
| Q1 24 | -2.6% | -104.5% |
资本支出强度BARKZLAB
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 1.7% | 2.6% | ||
| Q2 25 | 0.7% | 2.6% | ||
| Q1 25 | 1.5% | 1.5% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 1.4% | 1.3% | ||
| Q2 24 | 1.8% | 0.7% | ||
| Q1 24 | 1.8% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BARK
| Toys Accessories | $46.0M | 47% |
| Consumables | $30.2M | 31% |
| Commerce Segment | $18.9M | 19% |
| Other | $3.4M | 3% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
